Navigation Links
JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)
Date:2/27/2008

CHARLESTON, S.C., Feb. 27 /PRNewswire/ -- JSJ Pharmaceuticals is pleased to announce the introduction of its new aesthetic division, Vitivia(TM). Vitivia(TM) will focus on medically based aesthetics and utilize the clinical roots of JSJ Pharmaceuticals in the development of science-based, result-oriented products.

Vitivia(TM)'s first product introduction will be its Pro:Vitamin line. Topical vitamins have long been recognized as important tools in the anti-aging process. The benefits of most topical vitamins, however, have been limited by the inability to stabilize vitamins when exposed to air and light. For products that have attempted to address this stability issue, long lists of preservative agents have been the answer. Vitivia(TM)'s Pro:Vitamin has found an innovative solution to these challenges.

In light of the fact that today's consumers desire natural ingredients, free of chemical preservatives, fragrances, coloring, or other allergens, Vitivia(TM)'s Pro:Vitamin line combines pure concentrations of natural ingredients with the best of modern science. This formulation is then placed in individual biodegradable unit dose packaging insuring each application of Pro:Vitamin has never been exposed to light or air. As a result, the concentration of the first application is as pure and stable as the last.

"With the continued growth of medically based aesthetics, Vitivia(TM) will be an important growth factor for the future of JSJ Pharmaceuticals," stated JSJ's Chief Operating Officer, Jonathan Alba. "The introduction of the clinically proven Pro:Vitamin line will be a key part of the long-term foundation of the Vitivia(TM) division of JSJ," stated Alba.

Vitivia(TM)'s Pro:Vitamin line is available through physician offices nationally. For more information regarding the purchase or distribution of Vitivia(TM) products visit http://www.Vitivia.com or call 1-888-975-4848.

About JSJ:

JSJ Pharmaceuticals, based in Charleston, SC, is a growing specialty pharmaceutical company focused on the development and commercialization of prescriptive products to meet the diverse needs of patients suffering from a wide range of dermatological conditions. More information can be found about JSJ Pharmaceuticals at http://www.jsjpharm.com.

Media Contact:

Jon Knowles

843.965.8333 ext. 104

jknowles@jsjpharm.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE JSJ Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
2. NPS Pharmaceuticals Announces Senior Management Changes
3. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
4. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
5. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
7. Nycomed US Inc. Acquires Bradley Pharmaceuticals, Inc.
8. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
9. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
10. Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split
11. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)...  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... address significant unmet medical needs in rare diseases, ... ended December 31, 2016. "2016 ... we broadened our pipeline and pursued our vision ... with an initial focus on endocrinology," said ...
(Date:3/22/2017)... New York , March 22, 2017 ... is largely fragmented, states a research report by Transparency ... S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted ... in 2015. The prominent players in this market are ... expand their product portfolio, which is likely to lead ...
(Date:3/22/2017)... ... March 21, 2017 , ... Premier executive recruitment firm, Slone Partners, is proud ... Hunt Scanlon Media. , Hunt Scanlon Media is one of the most ... news source in the human capital sector. , “It is a great honor for ...
(Date:3/22/2017)... ... March 21, 2017 , ... The Conference Forum has announced the ... be held on May 10-11, 2017, at the Colonnade Hotel in Boston, MA. The ... Medical Officer peer-to-peer learning, benchmarking and support. , “The Chief Medical Officer faces a ...
Breaking Biology Technology:
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
Breaking Biology News(10 mins):